Company news
Neovasc Inc news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Neovasc Shareholders Approve Acquisition by Shockwave Medical
March 6, 2023
Neovasc Announces German Reimbursement Renewal
February 1, 2023
Shockwave Medical to Acquire Neovasc
January 17, 2023
Neovasc Announces Progress on COSIRA-II Clinical Trial
November 28, 2022
Neovasc Comments on European Heart Journal Publication
November 18, 2022
Neovasc Announces Third Quarter Financial Results and Provides Corporate Update
November 10, 2022
Neovasc Reducer Obtains U.S. Outpatient Reimbursement
November 8, 2022
Neovasc to Report Third Quarter Financial Results on November 10, 2022
October 27, 2022
Neovasc Provides Corporate Update Following Clinical Data Release
September 20, 2022
Neovasc to Participate in LSI Europe 2022 Emerging MedTech Summit
September 16, 2022
Neovasc Comments on New ICD-10-CM Diagnosis Codes for Refractory Angina
September 15, 2022
Neovasc Announces Key Events at TCT 2022
September 8, 2022
Neovasc to Participate in H.C. Wainwright 24th Annual Global Investment Conference
August 30, 2022
Neovasc Announces Second Quarter Financial Results and Provides Corporate Update
August 11, 2022
Neovasc to Report Second Quarter Financial Results on August 11, 2022
July 28, 2022
Neovasc Announces FDA Approval of Planned COSIRA II Sub-studies and Single Arm Registry to Allow Inclusion of Additional Specified Patient Populations
July 26, 2022
Neovasc Announces Direct Sales Operations in United Kingdom
July 5, 2022
Neovasc to Participate in Sidoti & Co. Summer Small Cap Virtual Investor Conference
June 8, 2022
Neovasc to Participate in H.C. Wainwright Global Investment Conference
May 23, 2022
Neovasc Regains Compliance with Nasdaq Minimum Bid Price Rule
May 16, 2022
Neovasc Announces First Quarter Financial Results and Provides Corporate Update
May 12, 2022
Neovasc to Report First Quarter Financial Results on May 12, 2022
April 29, 2022
Neovasc Comments on European Heart Journal Publication
April 28, 2022
Neovasc Announces Effective Date of Share Consolidation
April 27, 2022
Neovasc to Participate in Bloom Burton & Co. Healthcare Investment Conference
April 20, 2022
Neovasc Inc. Reports Results of Annual General and Special Meeting of Shareholders
April 13, 2022
Neovasc Announces Consolidation and Extension of Convertible Debt
March 24, 2022
Neovasc Announces Fourth Quarter and Fiscal Year 2021 Financial Results and Provides Corporate Update
March 10, 2022
Neovasc to Report Fourth Quarter and Full Year 2021 Financial Results on March 10, 2022
February 24, 2022
Neovasc Announces German Reimbursement Renewal and Commercial Progress
February 8, 2022
Independent Publication Reports Neovasc Reducer(TM) Demonstrates Cost Savings
February 4, 2022
Neovasc Announces Complete Dismissal of Securities Class Action Complaint with Prejudice
February 2, 2022
Neovasc Announces Publication Supporting the Neovasc Reducer(TM) Device
January 20, 2022
Neovasc Announces Case Series of First U.S. Reducer Implants Published in Peer-Reviewed Journal
January 18, 2022
Neovasc to Participate in H.C. Wainwright BIOCONNECT Virtual Conference
January 6, 2022
Neovasc Announces First Patient Enrollment in COSIRA-II Trial
January 5, 2022
Neovasc to Participate in Sidoti December Virtual Microcap Conference
December 1, 2021
Neovasc Reducer(TM) System Receives National Reimbursement in France
November 30, 2021
Neovasc Granted Additional 180 Calendar Day Grace Period for Nasdaq Bid Price Compliance
November 24, 2021
The National Institute for Health and Care Excellence of the United Kingdom Provides Positive Guidance for Neovasc Reducer System
November 24, 2021
Neovasc Announces Third Quarter 2021 Financial Results and Provides Corporate Update
November 9, 2021
Neovasc to Report Third Quarter 2021 Financial Results on November 9, 2021
November 1, 2021
Neovasc Reducer(TM) Featured in Polish Heart Journal
October 21, 2021
Neovasc REDUCER-I Study Published in EuroIntervention Journal
September 28, 2021
Neovasc to Participate in 2021 Benzinga Healthcare Small Cap Conference
September 23, 2021
Neovasc Announces FDA Approval of COSIRA-II Clinical Trial
September 16, 2021
Neovasc to Participate in H.C. Wainwright & Co. 23rd Annual Global Investment Conference
August 30, 2021
Neovasc Announces Submission of COSIRA-II Protocol Supplement to FDA
August 17, 2021
Neovasc Announces Second Quarter 2021 Financial Results
August 10, 2021
Neovasc to Report Second Quarter 2021 Financial Results on August 10, 2021
July 27, 2021
Decks
The 5 newest of 13 decks. Every deck is listed under its year.
- EuroPCR 2020
Conference · 11 slides · June 2020
- Investor Presentation (January 2015)
Investor deck · 22 slides · January 2015
- Investor Presentation (November 2014)
Investor deck · 23 slides · November 2014
- Investor Presentation (April 2013)
Investor deck · 19 slides · April 2013
- Investor Presentation (May 2012)
Investor deck · 21 slides · May 2012